Relapse/Refractory Myeloma Patient: Potential Treatment Guidelines

• J Clin Oncol. 2009 Dec 1;27(34):5676-7. Epub 2009 Sep 28.
  San Miguel JF.
  http://www.ncbi.nlm.nih.gov/pubmed/19786652
  http://jco.ascopubs.org/content/27/34/5676.long

The use of novel agents in the treatment of relapsed and refractory multiple myeloma

• Leukemia. 2009 Dec;23(12):2222-32. Epub 2009 Sep 10.
  Laubach JP, Mahindra A, Mitsiades CS, Schlossman RL, Munshi NC, Ghobrial IM, Carreau N, Hideshima T, Anderson KC, Richardson PG.
  http://www.ncbi.nlm.nih.gov/pubmed/19741729
  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133628/?tool=pubmed

Continuous Administration of Low-Dose Cyclophosphamide and Prednisone as a Salvage Treatment for Multiple Myeloma

• Clin Lymphoma Myeloma Leuk. 2010 Feb;10(1):51-5.
  Zhou F, Guo L, Shi H, Lin C, Hou J.
  http://www.ncbi.nlm.nih.gov/pubmed?term=Continuous%20Administration%20of%20Low-Dose%20Cyclophosphamide%20and%20Prednisone%20as%20a%20Salvage%20Treatment%20for%20Multiple%20Myeloma

Proteasome inhibitors in the treatment of multiple myeloma

• Leukemia. 2009 Nov;23(11):1964-79. Epub 2009 Sep 10.
  Shah JJ, Orlowski RZ.
  http://www.ncbi.nlm.nih.gov/pubmed/19741722

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

• Leukemia. 2009 Nov;23(11):2147-52. Epub 2009 Jul 23.
  Dimopoulos MA, Chen C, Spencer A, Niesvizky R, Attal M, Stadtmauer EA, Petrucci MT, Yu Z, Olesnyckyj M, Zeldis JB, Knight RD, Weber DM.
  http://www.ncbi.nlm.nih.gov/pubmed/19626046

Lenalidomide plus Dexamethasone for Relapsed Mutiple Myeloma in North America

• N Engl J Med. 2007 Nov 22;357(21):2133-42.
  Weber DM, Chen C, Niesvizky R, Wang M, Belch A, Stadtmauer EA, Siegel D, Borrello I, Rajkumar SV, Chanan-Khan AA, Lonial S, Yu Z, Patin J, Olesnyckyj M, Zeldis JB, Knight RD; Multiple Myeloma (009) Study Investigators.
  http://www.ncbi.nlm.nih.gov/pubmed/18032763
  http://www.nejm.org/doi/full/10.1056/NEJMoa070596

The Efficacy and Safety of Lenalidomide Plus Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients With Impaired Renal Function

• Cancer. 2010 Aug 15;116(16):3807-14.
  Dimopoulos M, Alegre A, Stadtmauer EA, Goldschmidt H, Zonder JA, de Castro CM, Masliak Z, Reece D, Olesnyckyj M, Yu Z, Weber DM.
  http://www.ncbi.nlm.nih.gov/pubmed/20564094
  http://onlinelibrary.wiley.com/doi/10.1002/cncr.25139/full